Sort by
Keyphrases
Endothelium
100%
Thyroid Hormones
100%
Vascular Smooth muscle Cells
100%
Endothelial Nitric Oxide Synthase (eNOS)
75%
Cyclooxygenase-1 (COX-1)
50%
A23187
50%
TP Receptor
50%
Thromboxane B2 (TXB2)
50%
Methyl
25%
Concentration-dependent
25%
Diabetes
25%
Interleukin-1β
25%
Human Umbilical Vein Endothelial Cells (HUVECs)
25%
Protein Expression
25%
Enzyme-linked Immunosorbent Assay (ELISA)
25%
Protein Level
25%
Carboxylic Acids
25%
Sprague-Dawley Rats
25%
Vasodilator
25%
Diabetic
25%
Diabetic Rats
25%
Keto
25%
Pyrrol
25%
Endothelial Nitric Oxide
25%
Prostaglandins
25%
Receptor Agonist
25%
Hypothyroidism
25%
Immunoblotting
25%
Femoral Artery
25%
Hyperthyroidism
25%
Endothelium-dependent
25%
Isometric Tension
25%
Prostanoids
25%
U46619
25%
Diabetic Endothelial Dysfunction
25%
Endothelium-dependent Contraction
25%
Triiodothyronine
25%
Endothelium-dependent Dilatation
25%
Medicine and Dentistry
Endothelial Nitric Oxide Synthase
100%
Vascular Smooth Muscle Cell
100%
Thyroid Hormone
100%
Vascular Smooth Muscle
66%
A23187
66%
Prostaglandin
66%
Thromboxane Receptor
66%
Thromboxane B2
66%
Diabetes
33%
Endothelial Dysfunction
33%
Vasoconstrictor
33%
Protein Expression
33%
Hypothyroidism
33%
Hyperthyroidism
33%
Nitric Oxide
33%
Enzyme Linked Immunosorbent Assay
33%
Human Umbilical Vein Endothelial Cell
33%
Femoral Artery
33%
Interleukin 1
33%
Prostaglandin Synthase
33%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
33%
Cyclooxygenase 1
33%
Isometrics
33%
Carboxylic Acid
33%
Immunoblotting
33%
Liothyronine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Nitric Oxide Synthase
100%
Thyroid Hormone
100%
Calcimycin
66%
Prostaglandin
66%
Thromboxane Receptor
66%
Thromboxane B2
66%
Carboxylate
33%
Sprague Dawley Rat
33%
Western Blot
33%
Receptor Agonist
33%
Liothyronine
33%
Enzyme-Linked Immunosorbent Assay
33%
Hyperthyroidism
33%
Interleukin 1
33%
Cyclooxygenase 1
33%
Prostaglandin Synthase
33%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
33%
Hypothyroidism
33%
Nitric Oxide
33%
Endothelial Dysfunction
33%